157 related articles for article (PubMed ID: 24705411)
1. Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study.
Basit A; Ahmad N; Khan AH; Javaid A; Syed Sulaiman SA; Afridi AK; Adnan AS; Haq Iu; Shah SS; Ahadi A; Ahmad I
PLoS One; 2014; 9(4):e93206. PubMed ID: 24705411
[TBL] [Abstract][Full Text] [Related]
2. Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan.
Qazi F; Khan U; Khowaja S; Javaid M; Ahmed A; Salahuddin N; Hussain H; Becerra MC; Golub JE; Khan AJ
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1556-9, i. PubMed ID: 22008773
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan.
Khan MA; Mehreen S; Basit A; Khan RA; Jan F; Ullah I; Ihtesham M; Khan A; Ullah U; Javaid A
Saudi Med J; 2015 Dec; 36(12):1463-71. PubMed ID: 26620989
[TBL] [Abstract][Full Text] [Related]
4. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
[TBL] [Abstract][Full Text] [Related]
6. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
[TBL] [Abstract][Full Text] [Related]
7. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
[TBL] [Abstract][Full Text] [Related]
8. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
[TBL] [Abstract][Full Text] [Related]
10. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant tuberculosis in Rawalpindi, Pakistan.
Khurram M; Khaar HT; Fahim M
J Infect Dev Ctries; 2012 Jan; 6(1):29-32. PubMed ID: 22240425
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
Alene KA; Viney K; Yi H; McBryde ES; Yang K; Bai L; Gray DJ; Xu Z; Clements ACA
PLoS One; 2018; 13(5):e0197880. PubMed ID: 29791488
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of adverse events in patient receiving community-based therapy for multidrug-resistant tuberculosis in Pakistan.
Javaid A; Khan MA; Jan F; Rauf M; Khan MA; Basit A; Mehreen S
Tuberk Toraks; 2018 Mar; 66(1):16-25. PubMed ID: 30020037
[TBL] [Abstract][Full Text] [Related]
14. Treatment of multidrug-resistant tuberculosis in Taiwan.
Suo J; Yu MC; Lee CN; Chiang CY; Lin TP
Chemotherapy; 1996; 42 Suppl 3():20-3; discussion 30-3. PubMed ID: 8980864
[TBL] [Abstract][Full Text] [Related]
15. Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan.
Irfan S; Rao N; Irfan M; Iftikhar I; Azizullah Z; Jabeen K; Hasan R
Int J Tuberc Lung Dis; 2019 Jul; 23(7):838-843. PubMed ID: 31439116
[No Abstract] [Full Text] [Related]
16. Prevalence of Multi-Drug Resistant
Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
[TBL] [Abstract][Full Text] [Related]
17. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.
Ahmad N; Javaid A; Basit A; Afridi AK; Khan MA; Ahmad I; Sulaiman SA; Khan AH
Int J Tuberc Lung Dis; 2015 Sep; 19(9):1109-14, i-ii. PubMed ID: 26260834
[TBL] [Abstract][Full Text] [Related]
18. Validity of Time to Sputum Culture Conversion to Predict Cure in Patients with Multidrug-Resistant Tuberculosis: A Retrospective Single-Center Study.
Javaid A; Ahmad N; Afridi AK; Basit A; Khan AH; Ahmad I; Atif M
Am J Trop Med Hyg; 2018 Jun; 98(6):1629-1636. PubMed ID: 29611497
[TBL] [Abstract][Full Text] [Related]
19. How many sputum culture results do we need to monitor multidrug-resistant-tuberculosis (MDR-TB) patients during treatment?
Janssen S; Padanilam X; Louw R; Mahanyele R; Coetzee G; Hänscheid T; Leenstra T; Grobusch MP
J Clin Microbiol; 2013 Feb; 51(2):644-6. PubMed ID: 23224098
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
